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UVA Irradiation of Human Skin Vasodilates
Arterial Vasculature and Lowers Blood Pressure
Independently of Nitric Oxide Synthase
Donald Liu1, Bernadette O. Fernandez2, Alistair Hamilton3, Ninian N. Lang4, Julie M.C. Gallagher5,
David E. Newby4, Martin Feelisch2 and Richard B. Weller1,3
The incidence of hypertension and cardiovascular disease (CVD) correlates with latitude and rises in winter. The
molecular basis for this remains obscure. As nitric oxide (NO) metabolites are abundant in human skin, we
hypothesized that exposure to UVA may mobilize NO bioactivity into the circulation to exert beneficial
cardiovascular effects independently of vitamin D. In 24 healthy volunteers, irradiation of the skin with two
standard erythemal doses of UVA lowered blood pressure (BP), with concomitant decreases in circulating nitrate
and rises in nitrite concentrations. Unexpectedly, acute dietary intervention aimed at modulating systemic nitrate
availability had no effect on UV-induced hemodynamic changes, indicating that cardiovascular effects were not
mediated via direct utilization of circulating nitrate. UVA irradiation of the forearm caused increased blood flow
independently of NO synthase (NOS) activity, suggesting involvement of pre-formed cutaneous NO stores.
Confocal fluorescence microscopy studies of human skin pre-labeled with the NO-imaging probe diamino-
fluorescein 2 diacetate revealed that UVA-induced NO release occurs in a NOS-independent, dose-dependent
manner, with the majority of the light-sensitive NO pool in the upper epidermis. Collectively, our data provide
mechanistic insights into an important function of the skin in modulating systemic NO bioavailability, which may
account for the latitudinal and seasonal variations of BP and CVD.
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INTRODUCTION
Cardiovascular disease (CVD) accounts for 30% of deaths
globally each year (Mendis et al., 2011). Hypertension is a
major risk factor for stroke, peripheral vascular disease, and
myocardial infarction. Systolic and diastolic blood pressure
(DBP) in mild hypertensives are lower in summer than winter
(Brennan et al., 1982), and mean population blood pressure
(BP) and hypertension prevalence increase with distance from
the equator (Rostand, 1997). The same seasonal and latitude
variation is seen in the incidence of acute coronary syndrome,
stroke, and cerebrovascular disease (Law and Morris, 1998;
Rosengren et al., 1999; Cottel et al., 2000; Oberg et al., 2000;
Zittermann et al., 2005).
Incident UVR from the sun decreases in intensity during
winter and with increasing latitude. UVB wavelengths of
sunlight support the synthesis of vitamin D, which is essential
to human health. Observational studies show an inverse
relationship between serum vitamin D levels and BP and
ischemic heart disease (Lehmann et al., 2001; Gouni-Berthold
et al., 2009); but interventional studies show no effect of
vitamin D supplementation on BP, the incidence of stroke, or
ischemic heart disease (Pittas et al., 2010). Although vitamin D
is a marker for sunlight exposure, the factors that lower BP and
cardiovascular mortality thus appear to be independent of it.
We have previously identified a rich store of nitric oxide
(NO) metabolites in human skin, yet its biological role remains
unknown. Nitrosothiols, nitrite, and nitrate are present in
significantly higher quantities in skin compared with the
circulation (Mowbray et al., 2009). Nitrate is the major
nitrogen oxide in the dermis and epidermis where it is
present at around 80mmol l–1, which is 2–3 times higher than
the circulating concentration (Paunel et al., 2005; Mowbray
et al., 2009). It is the ultimate oxidation product of NO and
has long been considered biologically inert. However, dietary
nitrate can lower BP following reduction to nitrite by oral
bacteria (Lundberg et al., 2008) and improve mitochondrial
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efficiency (Larsen et al., 2011), suggesting possible biological
activity.
We have proposed that solar UVA may mobilize nitrogen
oxides from cutaneous stores to the circulation to lower BP
and cardiovascular mortality (Feelisch et al., 2010) and here
demonstrate that UVA irradiation of the skin of normotensive
human volunteers lowers BP and causes arterial vasodilatation
in a NO synthase (NOS)-independent manner. Consistent with
the presence of NO storage forms in the epidermis and
liberation of NO from these pools, we observed a rise in
circulating nitrite contemporaneously with BP reduction and a
fall in plasma nitrate. These observations suggest a mechanism
for the modulation of systemic NO bioactivity by the skin.
RESULTS
Whole-body UVA irradiation lowers BP
A total of 24 resting healthy human volunteers were exposed
to UVA. During and for 20 minutes after active irradiation, the
mean arterial pressure fell significantly (3.50±0.73 mm Hg,
P¼0.0004). Sham irradiation caused a transient fall in mean
arterial pressure only during irradiation (2.80±0.98 mm Hg,
Figure 1a), suggesting an additional temperature effect. DBP
fell by 4.90±0.70 mm Hg during active irradiation; this was
sustained for 30 minutes (Figure 1b). These changes were
greater in the active than sham-irradiated group (P¼ 0.0071).
Sham irradiation caused a slight, but nonsignificant, reduction
in DBP of 2.79±1.02 mm Hg. Systolic BP showed no change
from baseline with either exposure (Figure 1c). Concomitant
with the drop in BP heart rate rose significantly following
active (3.57±1.08 b.p.m.) but fell slightly during and after
sham irradiation (Figure 1d); the difference between groups
was highly significant (P¼0.0012).
Effects on BP are not mediated by changes in temperature
To control for changes in temperature, volunteers were
covered with a metal foil ‘space blanket’ during irradiation,
which allowed the temperature rise induced by the lamp, but
prevented UVA irradiation reaching the skin. Sham and active
UVA irradiation groups showed a similar rise in core tem-
perature of o0.5 1C immediately after irradiation, which
represented a significant change from baseline (P¼0.34
between groups). Core temperature gradually returned to
baseline after active irradiation, but remained slightly elevated
in the sham group (Figure 1e; P¼ 0.1022). Skin surface
temperature rose by 1.53±0.05 and 1.76±0.06 1C in sham
and active irradiation groups, respectively (P¼0.7001;
Figure 1f), and returned similarly toward baseline after
irradiation.
UVA irradiation of human skin has opposite effects on
circulating nitrite and nitrate
In preliminary studies, plasma nitrite levels rose following
UVA irradiation. To minimize fluctuations in circulating NO
metabolite levels by dietary intake, variation study subjects
consumed a low nitrite/nitrate diet for 2 days before further
mechanistic study. Under these conditions, nitrite increased
from 0.50±0.04mM pre-UVA to 0.72±0.04mM immediately
after irradiation and remained elevated at 0.72±0.03mM for
40 minutes after irradiation. A nonsignificant trend toward
lower circulatory nitrite levels was observed during sham
irradiation (Figure 2a). These changes seemed to occur at the
expense of nitrate (Figure 2b). Circulatory nitrate fell signifi-
cantly from 11.79±0.64 to 8.99±0.40mM and remained
below baseline at 9.34±0.56mM 40 minutes after active
irradiation only. No significant changes were observed in
plasma S-nitrosothiol and vitamin D levels following active or
sham irradiation (Figure 2c and d); the delayed minor rise in
the latter may be due to the small UVB contribution of our
UVA source.
Varying systemic nitrate availability does not alter UVA-induced
hemodynamic effects
Although circulating nitrate levels in our subjects on the low
nitrate diet were clearly reduced compared with those on a
normal diet (10.7±0.6 vs. 20–30mM in individuals without
diet control; Mowbray et al., 2009), except during active UVA
irradiation, no significant differences in mean arterial pressure
changes were observed between the two groups (P¼0.7829;
Supplementary Figure S1 online). Similarly, acute elevation of
circulating nitrate by a nitrate-rich drink, which resulted in
levels of 107.8±15.4mM nitrate immediately before start of
the irradiation protocol, affected neither kinetics nor extent of
UVA-induced BP reduction from a low nitrate diet
(P¼ 0.1660; Supplementary Figure S2 online). These findings
are consistent with the notion that the cardiovascular effects
observed are not secondary to direct photolysis of blood
constituents in the dermal vasculature but require transloca-
tion of NO bioactivity from the skin. This further suggests that
systemic nitrate availability is not a limiting factor for light-
induced hemodynamic changes in humans.
UVA-induced effects on forearm blood flow (FBF) are
independent of NOS activity
Infusion of the pan-NOS inhibitor L-NG-monomethyl arginine
(L-NMMA) upstream of the vascular bed under study caused a
fall from baseline of FBF within 20 minutes. This was sustained
throughout the protocol during sham (2.34±0.21–
1.69±0.18 ml per 100 ml of tissues per minute, Po0.0001)
and active irradiations (2.56±0.37–1.51±0.15 ml per 100 ml
of tissues per minute, Po0.0001; Figure 3a and b) but did not
affect FBF in the non-infused, contralateral arm. UVA irradia-
tion of the L-NMMA-infused arm caused local vasodilatation,
with robust elevation of FBF over the L-NMMA baseline
30 minutes after irradiation (23.7±6.5% over baseline;
Figure 3a and c). No effects on FBF were observed with sham
irradiation (Figure 3b), and no changes whatsoever occurred
in the unirradiated contralateral arm (Figure 3d). FBF in the
L-NMMA-infused forearm, significantly increased in the active
compared with the sham irradiation group (P¼ 0.0002;
Figure 3c), although temperature changes in both groups
were almost identical (P¼0.9112; Supplementary Figure S3
online). No significant change in circulating nitrite was obser-
ved after UVA irradiation of the forearm (Supplementary
Figure S4A online), probably due to the much smaller skin
area exposed to light compared with the whole-body protocol.
Nitrate did fall significantly from baseline 20 and 40 minutes
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after active irradiation of the forearm (Supplementary Figure S4B
online).
UVA exposure of human skin releases NO from storage forms
located in the epidermis
Ex vivo human skin pre-labeled with the NO detecting
fluorochrome 4,5-diaminofluorescein diacetate (DAF-2DA)
was irradiated with the same UVA source used in our
in vivo studies. Irradiation increased cutaneous fluorescence
most markedly in the upper epidermis and stratum corneum
(Figure 4a and b). This was unaffected by the NOS antagonist
L-NMMA (Figure 4c), but completely abrogated by the NO
scavenger cPTIO (Figure 4d; compare with unirradiated
control, Figure 4e). Fluorescence intensity increased in a
fluence-dependent manner (Figure 4f).
In silico modeling of nitrite photolysis varies with latitude and
season
The chemical identity of the NO-containing species and
mechanistic details of the NO translocation from skin to
circulation are currently unknown. On the basis of our
observations that NO is released from skin in vitro and nitrite
is generated on whole-body exposure to UVA in vivo, we
surmised that nitrite, which also appears to be an intermediate
in nitrate photolysis (Mowbray et al., 2009 and Supplementary
Figure S5 online), contributes to skin-derived NO bioactivity.
The product of NO generated from nitrite photolysis in vitro
(Supplementary Figure S6 online) and incident UV energy
spectrum (Madronich et al., 2013) provides an estimate of the
NO release from sunlight-induced nitrite photolysis at different
latitudes (Supplementary Figure 5A online) and months
(Supplementary Figure 5B online). Our data suggest that
480% of NO release is accounted for by UVA. A significant
difference in calculated NO release occurs between June and
December at latitudes between 401 and 601 (Supplementary
Figure 5B online).
DISCUSSION
Current public health advice advocates avoidance of direct
sunlight even in temperate climes for fear of skin cancer.
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Figure 1. UVA lowers blood pressure (BP) independently of temperature. (a) Significant reduction of mean arterial pressure during UVA irradiation was
seen in both sham and active groups, but significant reduction after cessation of exposure was observed only in the active group; means±SEM (n¼ 24).
(b) Significant reduction of diastolic BP from baseline was seen during and up to 30 minutes after active irradiation; means±SEM (n¼ 24). (c) No significant change
in systolic BP was seen following UVA in either sham or active group. (d) Heart rate rose significantly immediately after active UVA, but not sham; means±SEM
(n¼ 24). (e) Core temperature did not change significantly from baseline in active or sham-irradiated groups; mean±SEM (n¼ 12). (f) Skin temperature rose
significantly from baseline in both treatment groups at all time points, but there was no difference between groups; means±SEM (n¼12). *Po0.05, **Po0.01,
***Po0.001.
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Discussions about minimum levels of sunlight exposure for
optimum health (focusing largely on vitamin D) are not new
(Gillie, 2010; Berwick et al., 2011), but arouse concerns over
solar overexposure. This study demonstrates that irradiation
with UVA, corresponding to natural sunlight exposure for
30 minutes at noon on a sunny day in Southern Europe,
vasodilates the arterial vasculature in NOS-independent
manner and reduces BP independently of changes in skin
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Figure 2. UVA increases nitrite and reduces circulating nitrate. (a) Nitrite rose significantly from baseline at all time points following active irradiation
and levels were significantly higher than those in the sham-irradiated group (P¼0.0176); means±SEM (n¼ 12). (b) Nitrate fell significantly from baseline
at all time points following active irradiation (Po0.0001). Nitrate levels were nonsignificantly lower in the active than sham-irradiated group (P¼ 0.0642);
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temperature. The time course of plasma nitrite/nitrate changes
and concomitant cardiovascular effects observed are all
consistent with the photolytic release of NO from a pre-
formed store and NO translocation from the skin to the
circulation, but not with vitamin D production (Feelisch
et al., 2010). These observations support a mechanism for
the modulation of systemic NO bioactivity and a possible role
of the skin in cardiovascular homeostasis. As with a previous
investigation (Oplander et al., 2009), our study is limited in as
much as all interventions were acute and carried out in
healthy normotensive young individuals. We do not know
whether UVA maintains its efficiency on repeated exposure
and whether or not its BP response varies with age, gender, or
disease. Moreover, nothing is known yet about the exact
nature of the cutaneous NO pool, its source of formation and
depletion–repletion kinetics. However, if confirmed and found
to also occur at lower intensity in a more chronic setting, these
results will have significant implications for public health
advice and change our risk–benefit assessment for sun
exposure.
We have shown that UVA exposure with two standard
erythemal doses (SEDs) to one side of the body (equating to a
skin surface area exposed when wearing a short-sleeved shirt
and shorts) leads to a small but significant fall in mean arterial
BP. This compares with a maximum daily ambient UV
irradiance of 45 SEDs at UK latitudes, and 60 SEDs in southern
European latitudes (Diffey, 2000). Mean arterial and DBP fell
following irradiation, but systolic BP did not change. DBP is a
function of total peripheral resistance, and its marked drop in
actively irradiated subjects, despite the compensatory rise in
heart rate (Figure 1d) suggests that UVA vasodilates the peri-
pheral vasculature. The relatively small BP changes we observe
may appear to be of minor significance, but a 10 mm Hg
change in DBP is responsible for a 2-fold change in cardio-
vascular or cerebrovascular mortality, and this risk alteration
is linear (Lewington et al., 2002). A reduction of DBP by
5 mm Hg decreases risk for stroke by 34% and coronary heart
disease by 21% (MacMahon et al., 1990). In fact, any amount
of BP reduction is protective against stroke and cardiovascular
mortality (Lewington et al., 2002; Lawes et al., 2004), and the
magnitude of changes observed in this study would appear to
be large enough to account for the standardized mortality
differences in populations living at different latitudes.
Dietary nitrate supplementation can lower BP (Lundberg
et al., 2008) but we found no augmentation of UVA-induced
hemodynamic effects in the normal diet group compared with
the low nitrate group. Oplander et al. (2009) also
demonstrated a BP reduction accompanied by increased
circulatory nitrite following UVA irradiation, but their
temperature control involved immersing subjects in warm
water. This procedure will have increased the circulating
volume by hydrostatic pressure on the great veins of the legs
and is thus not as accurate as our sham irradiation control. In
addition to BP changes, we show that UVA increases FBF in a
NOS and temperature-independent manner (Figure 3) and a
dose-dependent NO release within irradiated human skin
(Figure 4). Our data are aligned with the well-known seasonal
variation in BP at temperate latitudes, most clearly demon-
strated in the Medical Research Council studies on hyperten-
sion (Brennan et al., 1982). We have carefully controlled for
temperature using light-impermeable aluminum foil. The
sham-irradiated subjects had a slightly higher rise in core
and skin temperature (Figure 1e and f), but a smaller fall in BP
than the actively irradiated group. Moreover, sham irradiation
produced no rise in circulating nitrite, which we believe
contributes to the UVA-induced fall in BP. Our FBF study
showed no vasodilatation in the sham-irradiated group despite
the close matching of temperature with the actively irradiated
subjects (Supplementary Figure S3 online).
The skin contains large stores of nitrogen oxides, particu-
larly nitrate (Mowbray et al., 2009). Our in vivo data showing
concomitant reductions in circulating nitrate and rises in
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nitrite upon UVA irradiation (Figure 2c) suggest nitrate to
nitrite conversion is involved in light-induced BP reduction.
However, the fall in nitrate we observe is about 10 times
greater than the rise in nitrite. Moreover, acute modulation of
circulating nitrate by dietary means did not alter the extent of
light-mediated BP changes (even after elevating plasma levels
by an order of magnitude; Supplementary Figures S1 and S2
online), supporting the idea that light-induced cardiovascular
effects in vivo require bioactivation of a cutaneous rather than
a circulating NO store. Notwithstanding the possibility that
enzymatic nitrate to nitrite reduction (Jansson et al., 2008)
may be enhanced by light, the rapid onset of biochemical and
hemodynamic changes strongly suggests involvement of a
photolytic process. Along with others (Suschek et al., 2010;
Oplander et al., 2010), we (Rodriguez et al., 2003) have
shown that nitrite readily yields NO on irradiation with UV.
By comparison, the yield of NO from direct nitrate photolysis
is very low, but thiols markedly enhance this process (Dejam
et al., 2003). The SH-containing amino-acid cysteine is widely
present in the epidermis, either in its free form (along with
other small thiols such as glutathione) or as protein consti-
tuent, in particular in the upper viable epidermal layers
(Ogawa et al., 1979). Cysteine-mediated enhancement of
nitrate photolysis to NO, with intermediary nitrite formation,
may thus be involved in the cardiovascular effects we observe
(Supplementary Figure S5 online). UVA will penetrate 500mm
deep into the skin (Tuchin, 1993), so these reactions can occur
in the epidermis, dermis, or even the dermal vasculature. The
greatest intensity of DAF-2DA-related fluorescence following
UVA was in the upper epidermis and stratum corneum,
and was completely abolished by NO scavenging. These
superficial sites receive the greatest UV energy, and we can
speculate on the origin of these cutaneous NO stores.
Both endothelial and inducible NOS are expressed in
human epidermis; generation of NO from sweat nitrate
(Weller et al., 1996) and conversion of ammonia to nitrite
(Whitlock and Feelisch, 2009) occur on the skin surface. Thus,
epidermal NO stores may be formed primarily from NOS
activity and be replenished by ‘‘bathing’’ in nitrite/nitrate-
containing sweat in addition to contact with extracellular
fluid. This would not explain the drop in circulating nitrate we
see upon UVA exposure; if not due to direct photolysis the
latter can only mean that nitrate is taken up by cells in
response to irradiation with light; this deserves further
investigation. As NO rapidly diffuses over short distances,
nitrite/nitrate photolysis has the potential to deliver NO to the
dermal vasculature, and thus the systemic circulation. We
identified pre-formed NO stores in the skin as the source of
UVA-induced cardiovascular effects, as these still occur
following NOS inhibition (Figure 3). Dilatation of forearm
blood vessels, reduction in BP, and rise in circulating nitrite all
lasted for at least 30 minutes after UV irradiation, indicating
the involvement of longer-lived NO-containing metabolites as
carriers of bioactivity. Surprisingly, plasma nitrosothiol levels
did not change (Figure 2d), but nitrite itself has biological
activity and can nitrosylate cell/tissue constituents (Bryan
et al., 2005). Thus, the skin has the potential to contribute
not only to cardiovascular homeostasis but also to distal organ
protection by increasing the circulating NO metabolite pool
(Feelisch et al., 2010).
The spectrum of incident UV at the earth’s surface varies
with latitude and season. Shorter wavelength radiation is
preferentially filtered out by the atmosphere. As the azimuth
angle decreases with increased latitude and seasonal change
to winter, the thickness of the atmosphere through which solar
radiation passes increases, with a consequent reduction in the
UVB:UVA ratio, and overall incident energy at the earth’s
surface. Although the exact chemical composition of the
cutaneous NO pool is currently unknown, nitrite is a likely
constituent. Nitrite photolysis is wavelength and energy
dependent, and the product of its action spectrum with
geographic and seasonal incidence data may give an indica-
tion of the rate of NO release from cutaneous stores by latitude
and season (Figure 5). UVB has a higher energy per photon
compared with UVA, but only penetrates to the epidermis.
Our calculations show that UVA is responsible for the majority
of the NO release, with significant seasonal variation at
latitudes between 401 and 601 (Figure 5b), which correlates
with the known seasonal variation in BP and cardiovascular
mortality at these temperate latitudes. Less NO is produced
further from the equator, which mirrors the relationship of
latitude with BP and hypertension prevalence.
Serum vitamin D levels correlate inversely with BP, but
vitamin D supplementation has no effect on BP and cardio-
vascular morbidity/mortality (Pittas et al., 2010). Our data
suggest that while vitamin D levels are a biomarker for
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sunlight exposure, the mechanism by which sunlight lowers
BP is predominantly via UVA-mediated photolysis of
cutaneous nitrite and/or nitrate to NO. This finding has
significant public health implications. High latitude countries
such as Scotland carry a heavy burden of cardiovascular and
cerebrovascular disease, and this has persisted despite
interventions taken to reduce other risk factors. Concerns
over rising rates of melanoma and non-melanoma skin
cancers, for which excess sunlight is a risk factor, have led
to advice on minimizing exposure to sunlight and maximizing
the use of sunblock. Age-standardized melanoma mortality
(Forsea et al., 2012) is much lower than that from CVD or
cerebrovascular disease (Nichols et al., 2012; 2.6 vs. 112.5 vs.
59.5/100,000 per year in 2008). We are concerned that well-
meaning advice to reduce the comparatively low numbers of
deaths from skin cancer may inadvertently increase the risk of
death from far higher prevalent CVD and stroke, and goes
against epidemiological data showing that sunlight exposure
reduces all-cause and cardiovascular mortality (Yang et al.,
2011; Brondum-Jacobsen et al., 2013).
MATERIALS AND METHODS
Clinical study protocols
Human studies followed Declaration of Helsinki protocols and were
approved by the South East Scotland Local Research Ethics Commit-
tee (reference 08/S1102/6 and 11/AL/0130). Subjects gave written,
informed consent. Studies were conducted in a quiet, temperature-
controlled room (22–24 1C).
UV light source
A Waldmann GH-8 ST unit (Herbert Waldmann GmbH, Villingen-
Schwenningen, Germany) containing 8 F851 100 W UVA bulbs
(320–410 nm; maximum 351 nm), producing 20 J cm–2 at 20 cm
(two SEDs) was used for clinical and ex vivo studies.
BP study and dietary intervention
A total of 24 healthy volunteers (18 men and 6 women 22±0.5 years;
subject skin types were (1) I, (4) II, (4) III, (6) IV, (2) V and (7) not given;
Supplementary Table S1 online) were randomly assigned to two
groups of 12: in one, a low nitrite/nitrate diet (Wang et al., 1997)
was given for 2 days before UVA irradiation; in the other group
volunteers enjoyed an unrestricted diet. Subjects in the low nitrate
group participated in a follow-up study 1 week later in which systemic
nitrate levels were acutely raised immediately before UVA irradiation
by ingestion of 500 mg potassium nitrate (Larsen et al., 2007).
Subjects wore underwear during irradiation. After resting supine for
30 minutes wearing comfortable clothing, they were sham irradiated
for 22 minutes. Aluminum foil blocked incident UVA radiation
reaching the skin while allowing surface and body temperature to
rise. Following a 60 minutes observation period, active UVA irradia-
tion was given (20 J cm–2 over 22 minutes). Subjects were monitored
for a further 60 minutes. BP and heart rate were measured in triplicate
every 10 minutes using a semi-automated non-invasive oscillometric
sphygmomanometer. Blood was taken at 20 minutes intervals, cen-
trifuged, snap frozen and stored at  80 1C (Feelisch et al., 2002)
for later determination of plasma NO metabolites. Core temperature
was measured by axillary skin (MLT422/A, AD Instruments,
Chalgrove, UK) or tympanic probe (Genius 2, Tyco Healthcare,
Hampshire, UK). Surface temperature was measured by MLT422/A
probes on chest and back.
FBF study
A total of 12 healthy male volunteers (22±1 years; skin types were (4)
II, (6) III, (1) IV and (1) not given) had cannulation of the non-dominant
brachial artery with a 27G wire steel needle. FBF was measured in
infused and non-infused arms by venous occlusion plethysmography
using mercury-in-silastic strain gauges (Benjamin et al., 1995).
Volunteers attended on two occasions for sham (temperature control)
or active UVA irradiation (20 J cm–2) of the cannulated forearm. The
sequence was randomly allocated. NOS-derived NO production was
blocked by continuous intra-brachial artery infusion of L-NMMA
(8mmol minute–1) in the irradiated arm on both visits. Skin tempera-
ture was monitored and controlled with an electric fan. Blood samples
(n¼ 11, due to difficult venous access in one subject) were drawn from
irradiated and contralateral arm for NO metabolite analyses.
Measurement of circulating NO metabolites and vitamin D
levels
All biochemical analyses were conducted blinded, immediately after
thawing samples. Nitrosothiols (RSNO) and other nitroso species
were quantified using group-specific denitrosation by injection of pre-
treated plasma aliquots into tri-iodide-containing reaction mixture, at
60 1C and constantly purged with nitrogen. NO liberated from
reduction of nitrosated proteins was measured by gas phase chemi-
luminescence (CLD 77am sp; EcoPhysics (Durnten, Switzerland);
Rassaf et al., 2002). Oxidation products of NO (nitrite and nitrate)
were quantified by a dedicated ion chromatography system (ENO20
Analyzer; Eicom, Kyoto, Japan), following deproteinization with
methanol (1:1 v/v) and centrifugation immediately before loading
the autosampler. Vitamin D levels were measured as total 25-hydroxy
vitamin D in paired blood samples drawn before and 24 hours after
UVA exposure using HPLC-atmospheric pressure chemical ionization
mass spectrometry (Knox et al., 2009).
Fluorescence microscopy study
Redundant skin from abdominoplasty procedures (n¼ 9) was snap
frozen and microtomed to 5mm sections; later incubated with 10mM of
the NO fluorochrome DAF-2DA for 1 hour at room temperature
(Rodriguez et al., 2005). Sections were irradiated with the same light
source used in human studies. Paired sections were co-incubated with
1 mM L-NMMA or 200mM c-PTIO. An adjacent section was conven-
tionally stained with hematoxylin and eosin. Sections were examined
using a Leica SP5C spectral confocal laser scanning microscope
(Wetzlar, Germany) and fluorescence intensities quantified using
Image-Pro Plus (Media Cybernetics, Rockville, MD).
Data and statistical analysis
Data were analyzed using SPSS (version 17.0, IBM, Portsmouth, UK)
and Graph Pad Prism 5 (La Jolla, CA) and expressed as means±SEM
unless otherwise stated. Differences were compared by one-way or
two-way repeated-measures analysis of variance, after Bonferroni’s
correction for multiple comparisons. Po0.05 was considered statis-
tically significant.
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